Premium
[P1–020]: SCREENING FDA‐APPROVED COMPOUNDS IN A TREM2 CELL MODEL OF ALZHEIMER's DISEASE
Author(s) -
Rutter Hannah,
Lim Yau Mun,
Corcoran Jonathan,
Hodges Angela
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.087
Subject(s) - trem2 , microglia , neuroprotection , receptor , phagocytosis , biology , pharmacology , immunology , cancer research , inflammation , biochemistry
Neurology, Kuopio University Hospital, Kuopio, Finland; Institute of Health Sciences/Geriatrics, University of Oulu and Oulu University Hospital, Oulu, Finland; Oulu City Hospital, Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland; Department ofMedicine, Geriatric Clinic, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland; Karolinska Institutet, Stockholm, Sweden; Karolinska Institutet-Stockholm University, Stockholm, Sweden. Contact e-mail: anna.rosenberg@uef.fi
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom